A new study from the University of Michigan Health Rogel Cancer Center reveals a connection between the most common type of white blood cells, which act as a first defense in the body s immune system, and a severe complication of CAR T-Cell immunotherapy.
Oncology research booms: Global investigator sites double in just five years biopharma-reporter.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biopharma-reporter.com Daily Mail and Mail on Sunday newspapers.
Global cancer trial investigator sites have increased 50% in just five years but led to a rise in the number of poorly performing sites, new research ha.